A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility.

Saved in:
Bibliographic Details
Title: A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility.
Authors: Modlin IM; Department of Surgery, Yale University School of Medicine, New Haven, USA., Kidd M; Wren Laboratories, Branford, USA., Falconi M; Department of Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy., Filosso PL; Department of Surgical Sciences, Università degli Studi di Torino, Turin, Italy., Frilling A; Department of Surgery and Cancer, Imperial College London, London, UK., Malczewska A; Department of Endocrinology and Neuroendocrine Tumours, Medical University of Silesia, Katowice, Poland., Toumpanakis C; Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK., Valk G; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Pacak K; Medical Neuroendocrinology, National Institutes of Health, Bethesda, USA., Bodei L; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA., Öberg KE; Department of Endocrine Oncology, University Hospital, Uppsala, Sweden. Electronic address: kjell.oberg@medsci.uu.se.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Nov; Vol. 32 (11), pp. 1425-1433. Date of Electronic Publication: 2021 Aug 11.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1569-8041
DOI:10.1016/j.annonc.2021.08.1746